Last reviewed · How we verify
NCT03797755: PROPER
Prognosis of Patient Evaluated for Palliative Radiotherapy
trial testing palliative radiotherapy in Cancer in 450 participants. Status unknown.
31 December 2019
Quick facts
| Lead sponsor | Tuen Mun Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 450 |
| Start date | 1 January 2019 |
| Primary completion | 31 December 2019 |
| Estimated completion | 31 December 2019 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- palliative radiotherapy
Conditions studied
- Cancer — all drugs for Cancer →
- Radiotherapy — all drugs for Radiotherapy →
Sponsor
Tuen Mun Hospital
Who can join
18 and older, any sex, with Cancer or Radiotherapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Many patients with incurable cancer will receive palliative oncological treatment before their death, and radiotherapy (RT) is an important element of this. The aim of palliative RT is to alleviate symptoms and improve quality of life. An accurate and practical survival prediction model for metastatic cancer patient receiving palliative RT can assist the decision making (ranging from best supportive treatment alone for expected short survival, to dose escalation for potential better disease control). The available survival prediction models (such Survival Prediction Score using Number of Risk Factors by Chow et al and TEACHH model) have been developed in the Western world. We therefore perform a prospective observational study 1) to assess the overall survival of patients evaluated for palliative RT at a tertiary hospital in Hong Kong, and 2) to validate the prognostic score systems in our population.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03797755
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of palliative radiotherapy
Trials testing the same drug.
- NCT06524804 — A Phase Ib/II Study of BY101298 , an Oral DNA-PK Inhibitor, Combined with Radiotherapy in Patients with Malignant Solid · Phase 1, PHASE2 · terminated
- NCT03862911 — Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer · NA · active not recruiting
- NCT03927495 — KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma · Phase 2 · unknown
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other Tuen Mun Hospital trials
Trials by the same sponsor.
- NCT06842927 — Dialysis Efficiency and Transporter Evaluation Computational Tool in Peritoneal Dialysis · enrolling by invitation
- NCT07293468 — Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH) · Phase 2, PHASE3 · recruiting
- NCT05796076 — Virtual Reality to Reduce Anxiety and Pain During Suturing Procedure · NA · completed
- NCT05182203 — Safety and Retention Rate of the JAK and TNF Inhibitors in Rheumatoid Arthritis: a Real-life Experience · completed
- NCT04091243 — Romosozumab Versus Denosumab for Osteoporosis in Long-term Glucocorticoid Users · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03797755 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tuen Mun Hospital
- Last refreshed: 9 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03797755.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing